International Circulation: What impact will CURRENT OASIS 7 have on antiplatelet therapy in patients with ACS?

《国际循环》：CURRENT OASIS 7 研究将对ACS患者的抗血小板治疗产生怎样的影响？

Professor Mehta: It will have a significant impact because most cardiologists and interventional cardiologists are currently using clopidogrel.  It is a very simple maneuver to administer two pills instead of just one pill for 7 days to patients.  A lot of centers are already using the higher loading dose.  The cost implications are negligible and the benefits on a reduction in stent thrombosis are large.

S R Mehta教授：该研究将产生重大影响，因为大多数心脏病专家和介入心脏病专家目前都在使用氯吡格雷。给予患者2粒氯吡格雷药片共7天来取代原先仅1片的给药方法是一种非常简单的调整。很多中心已经在使用更高的负荷剂量。这对成本的影响可以忽略不计，而在减少支架血栓形成上的获益却是巨大的。

上一页  [1]  [2]  [3]  [4]  下一页